You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 11,318,100


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,318,100 protect, and when does it expire?

Patent 11,318,100 protects SINCALIDE and is included in one NDA.

This patent has three patent family members in three countries.


Drugs Protected by US Patent 11,318,100

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Maia Pharms Inc SINCALIDE sincalide POWDER;INTRAVENOUS 210850-001 Nov 22, 2022 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ACCELERATE THE TRANSIT OF A BARIUM MEAL THROUGH THE SMALL BOWEL, THEREBY DECREASING THE TIME AND EXTENT OF RADIATION ASSOCIATED WITH FLUOROSCOPY AND X-RAY EXAMINATION OF THE INTESTINAL TRACT ⤷  Sign Up
Maia Pharms Inc SINCALIDE sincalide POWDER;INTRAVENOUS 210850-001 Nov 22, 2022 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y STIMULATE GALLBLADDER CONTRACTION, AS MAY BE ASSESSED BY VARIOUS METHODS OF DIAGNOSTIC IMAGING, OR TO OBTAIN BY DUODENAL ASPIRATION A SAMPLE OF CONCENTRATED BILE FOR ANALYSIS ⤷  Sign Up
Maia Pharms Inc SINCALIDE sincalide POWDER;INTRAVENOUS 210850-001 Nov 22, 2022 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y STIMULATE PANCREATIC SECRETION IN COMBINATION WITH SECRETIN PRIOR TO OBTAINING A DUODENAL ASPIRATE FOR ANALYSIS ⤷  Sign Up
Maia Pharms Inc SINCALIDE sincalide POWDER;INTRAVENOUS 210850-001 Nov 22, 2022 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y STIMULATE GALLBLADDER CONTRACTION. AS MAY BE ASSESSED BY VARIOUS METHODS OF DIAGNOSTIC IMAGING, OR TO OBTAIN BY DUODENAL ASPIRATION A SAMPLE OF CONCENTRATED BILE FOR ANALYSIS ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,318,100

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 3073944 ⤷  Sign Up
European Patent Office 3672616 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2019040904 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.